Genelux (GNLX) Stock Chart & Stock Price History $5.21 -0.04 (-0.76%) As of 01:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Genelux Stock Price Performance The Genelux (GNLX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 96.60%, with a year-to-date return of 120.76%. In the past month, the stock has increased 31.90%, reflecting recent market activity. As of the latest close, Genelux traded at $5.25 with a market cap of $198.29 million and volume of 172,644 shares. Receive GNLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genelux and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-8.11%1 Month Performance+31.90%3 Month Performance+54.14%Year-To-Date Performance+120.76%1 Year Performance+96.60% GNLX Stock Chart for Tuesday, October, 14, 2025 GNLX Chart by TradingView Genelux Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025$5.07$5.25+3.55%$5.50$5.01172,644 shs$198.29 million10/10/2025$5.67$5.07-10.58%$5.65$4.95225,747 shs$191.49 million10/09/2025$4.75$5.67+19.37%$5.72$4.76368,482 shs$214.17 million10/08/2025$4.71$4.75+0.85%$4.79$4.61100,162 shs$179.41 million10/07/2025$4.54$4.71+3.74%$4.83$4.51120,936 shs$177.90 million10/06/2025$4.45$4.54+2.02%$4.66$4.4489,092 shs$171.49 million10/03/2025$4.39$4.45+1.37%$4.61$4.4099,337 shs$168.09 million10/02/2025$4.40$4.39-0.23%$4.44$4.17111,963 shs$165.81 million10/01/2025$4.20$4.40+4.76%$4.44$4.1949,582 shs$166.19 million09/30/2025$4.25$4.20-1.18%$4.40$4.1599,977 shs$158.65 million Get the Latest News and Ratings for GNLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genelux and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025$4.20$4.25+1.19%$4.41$4.15104,050 shs$160.52 million09/26/2025$4.21$4.20-0.24%$4.45$4.0826,715 shs$158.63 million09/25/2025$4.37$4.21-3.66%$4.43$4.18120,194 shs$159.01 million09/24/2025$4.34$4.37+0.69%$4.59$4.22110,568 shs$165.07 million09/23/2025$4.11$4.34+5.60%$4.50$4.13206,968 shs$163.92 million09/22/2025$4.16$4.11-1.20%$4.20$3.99104,387 shs$155.24 million09/19/2025$4.01$4.16+3.74%$4.24$3.95211,234 shs$157.12 million09/18/2025$3.91$4.01+2.56%$4.17$3.83138,697 shs$151.47 million09/17/2025$4.09$3.91-4.40%$4.21$3.90171,449 shs$147.68 million09/16/2025$3.92$4.09+4.34%$4.14$3.76289,719 shs$154.48 million09/15/2025$3.95$3.92-0.76%$4.00$3.82164,120 shs$148.07 million Related Companies Esperion Therapeutics Stock Price Chart Keros Therapeutics Stock Price Chart Siga Technologies Stock Price Chart Inventiva Stock Price Chart COMPASS Pathways Stock Price Chart Monopar Therapeutics Stock Price Chart Arcturus Therapeutics Stock Price Chart KalVista Pharmaceuticals Stock Price Chart Savara Stock Price Chart Gossamer Bio Stock Price Chart Receive GNLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genelux and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GNLX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genelux Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Genelux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
